Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


BioCryst Reports National Institute of Allergy and Infectious Diseases $44M Contract To Advance Development Of Galidesivir


Benzinga | Aug 31, 2020 09:29AM EDT

BioCryst Reports National Institute of Allergy and Infectious Diseases $44M Contract To Advance Development Of Galidesivir






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC